Clinical trials are research studies that evaluate new medical approaches and increase scientific understanding of a wide variety of diseases. We research these new medical approaches so that we can evaluate new devices and new medications for a better understanding of how we can treat diseases for individuals. At St. Hope, we believe that this research is key to improving health care throughout the world. Our goal is to quickly translate research findings into clinical care that benefits all patients. Through clinical trials, our researchers learn which approaches are more effective than others.
St. Hope actively engages interest in the following clinical trials:
- Treatment clinical trials – Researching ways to treat new diseases – this type of clinical trial tests new drugs, medical devices, medical procedures, or combinations of treatments.
- Prevention clinical trials – Researching ways to prevent disease – this type of trial searches for better approaches to prevent diseases through new medicines, vaccines or lifestyle changes.
- Screening clinical trials – Researching ways to test an individual for a new condition (genetic and diagnostic testing) – this type of trial searches for new ways to test for the presence of a disease or health condition.
- Quality of life clinical trials – Researching ways to make a sick person more comfortable when they have a chronic disease, and how to prolong their lives – this type of trial explores ways to improve comfort and quality of life for chronically ill individuals.
Benefits of Clinical Trials
Involvement in a clinical trial is strictly voluntary, but people who participate can experience benefits. Here are some benefits you could receive as a clinical trial participant:
- Access to promising drugs, medical devices, or treatment approaches before the general public
- All Lab Work (EKG, Ultrasound, Diagnostic Procedures)
- Free or subsidized health care for the duration of the trial
- Active involvement in your own treatment plan
- Expert medical care at a leading health care facility
- Regular Appointments In Accordance With Protocol For Clinical Trial
- Stipend For Time And Travel (Daycare, Transportation, Etc)
- Close monitoring of your health care and side effects
The St. Hope Clinical Research Team consists of 3 Study Coordinators, 1 Regulatory and 1 Senior Director Of Clinical Research.
The St Hope Foundation receives research studies from sponsors (pharmaceutical or biotech companies) and does research using grants from these companies to conduct the studies using the company’s medications.
Many of the study protocols are geared towards patients with HIV and for the prevention of HIV.
For some studies, The St Hope Foundation has been the number one research facility in the world by patient enrollment.
Because of our status in the research community, companies come back to St Hope as often as they can because they know we bring in high quality patients and do high quality work as well.
St Hope’s clinical research department is also one of the highest referral sights from the City Of Houston and surrounding clinics for research. Our research department also receives referrals from within our own clinics (5 in the Houston area). Once we receive a referral, our clinical research department evaluates the patient to verify that they qualify for the research study protocol.
How Patients Enroll In A Clinical Research Study
To enroll in a St. Hope Clinical Research Trial, participants must first complete the online form found below. Once the form has been completed, participants will be contacted by a member of our Research Team for a pre-screening interview via phone to determine whether the patient qualifies for the trial.
The patient is asked to review an “informed consent” agreement stating that they understand the clinical trial they are participating in. They are given opportunity to review the “informed consent” form with family, friends, or legal counsel.
Once the patient is qualified, an appointment is made for their first visit. At that appointment, the entire process is carefully explained., and they sign the informed consent form. Any questions are answered. Patient participation is 100% voluntary, so a patient may withdraw from a clinical trial at any time.
If a patient elects to withdraw from a clinical trial, St. Hope works to “bridge” their treatment for Standard Of Care. Of course we want the patient to continue their treatment, regardless of where they choose to continue it, and we work to make sure they are continuing with the type of treatment that is best for them.
The first objective of every treatment plan is patient safety. Patients are closely monitored to detect any abnormality in lab work, or any side effects from the medication.
Often in our clinical trials, we conduct “resistance testing”. This involves an extensive blood test that reveals whether the patient has something called “transmitted resistance”. Even if the patient has never been treated previously for a disease, the person they contracted the disease from may have taken medication for the disease, and the disease may have developed a resistance to certain medications. By testing for transmitted resistance, it allows us to focus treatment using drugs that the disease has never previously encountered, greatly increasing the chances for positive outcome.
Current Clinical Trials
Gout and Heart Research Study
Type 2 Diabetes Medication Research Study
If you decide to participate in a clinical trial at St. Hope, you’ll play in important role in advancing scientific knowledge and helping future patients. Complete the form below:The following two tabs change content below.St. Hope is an innovative and federally-qualified community health center offering comprehensive medical, dental, pharmacy and clinical research.
Latest posts by St. Hope Foundation (see all)
- Baskets of Hope for the Holidays - November 18, 2017
- Health Insurance Marketplace: Applying For Or Renewing Coverage? St. Hope Can Help! - November 13, 2017
- Happy 18th Anniversary St. Hope! - November 4, 2017
- Patients Are Our #1 Priority - October 30, 2017